SRE:BMVSempra Analysis

Sempra (SRE) is trading at $95.94, comfortably above its 20‑day SMA ($94.06) and 200‑day SMA ($86.07), indicating a bullish technical backdrop. The RSI of 63.6 points to momentum but not yet overbought, while the MACD histogram is slightly negative, hinting at short‑term caution. Fundamentals show a trailing P/E of 34.9 versus an industry average of 23.4, suggesting the stock is overvalued on a price‑earnings basis, though the forward P/E of 17.4 narrows that gap. The dividend yield of 2.74% is attractive, yet the payout ratio of 94% and a massive negative free cash flow (-$27.7 B) raise questions about sustainability. The balance sheet is heavily leveraged (debt‑to‑equity 83.4) and the company’s cash position is modest. Recent news reports a Q4 earnings beat and a Morgan Stanley upgrade, supporting the analyst consensus “Buy” and a median price target of $102.5, but the DCF fair value of $12.77 starkly contrasts with the current price, underscoring valuation concerns.
Overall, Sempra benefits from stable utility demand and a solid dividend, but high leverage, cash‑flow deficits, and an elevated valuation temper enthusiasm. Investors should weigh the bullish technical signals and earnings momentum against the financial strain and potential dividend risk.